Quarterly report pursuant to Section 13 or 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.22.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2022
Disclosure Text Block Supplement [Abstract]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table presents information related to stock options at March 31, 2022:

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Exercisable

 

 

Exercise

 

 

Number of

 

 

Remaining Life

 

 

Number of

 

 

Price

 

 

Options

 

 

In Years

 

 

Options

 

 

$

Under 2.00

 

 

 

736,000

 

 

 

9.9

 

 

 

75,000

 

 

 

2.00-2.99

 

 

 

1,000,375

 

 

 

9.4

 

 

 

549,375

 

 

 

3.00-3.99

 

 

 

587,466

 

 

 

4.1

 

 

 

387,466

 

   

4.00-4.99

     

1,547,916

     

6.2

     

1,136,573

 

 

 

5.00-5.99

 

 

 

156,132

 

 

 

6.9

 

 

 

124,046

 

 

 

6.00-6.99

 

 

 

461,542

 

 

 

5.0

 

 

 

389,515

 

 

 

7.00-7.99

 

 

 

186,720

 

 

 

6.6

 

 

 

176,721

 

 

 

Over 8.00

 

 

 

193,333

 

 

 

7.6

 

 

 

168,461

 

 

 

 

 

 

 

4,869,484

 

 

 

7.2

 

 

 

3,007,157

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Exercisable

 

Exercise

 

 

Number of

 

 

Remaining Life

 

 

Number of

 

Price

 

 

Options

 

 

In Years

 

 

Options

 

$

5.00

 

 

 

125,000

 

 

 

6.9

 

 

 

91,664

 

 

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the Plan for the three months ended March 31, 2022 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at December 31, 2021

    4,568,484     $ 4.57       6.9     $ -  

Grants

    736,000     $ 1.47       10.0     $ -  

Forfeited/expired

    (435,000

)

  $ 5.36                  

Outstanding at March 31, 2022

    4,869,484     $ 4.03       7.2     $ -  

Exercisable at March 31, 2022

    3,007,157     $ 4.68       6.4     $ -  

 

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following assumptions were used in determining the fair value of options during the three months ended March 31, 2022:

 

Risk-free interest rate

 

 

1.17% - 2.43

%

Dividend yield

 

 

0

%

Stock price volatility

 

 

83.83% to 92.93

%

Expected life

 

6 to 10 years

 

Weighted average grant date fair value

 

$

1.06

 

 

Risk-free interest rate

 

 

0.44% - 1.95

%

Dividend yield

 

 

0

%

Stock price volatility

 

 

83.86

%

Expected life

 

0.25 – 2 years

 

 

Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block]

The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at March 31, 2022:

 

 

Exercise

 

 

Number

 

Expiration

 

Price

 

 

Outstanding

 

Date

 

$

1.40

     

2,613,130

 

September 2025

 

$

4.80

 

 

 

250,000

 

February 2025 to July 2026

 

$

6.16

 

 

 

568,910

 

November 2027

 

 

 

 

 

 

3,432,040

 

 

 

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the warrant activity for the three months ended March 31, 2022 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at December 31, 2021

    818,910     $ 5.74       5.3     $ -  

Issued

    2,613,130     $ 1.40       3.5       -  

Outstanding at March 31, 2022

    3,432,040     $ 2.44       3.8     $ -  
                                 

Vested and expected to vest at March 31, 2022

    3,432,040     $ 2.44       3.8     $ -  

Exercisable at March 31, 2022

    818,910     $ 5.74       5.0     $ -  

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes the restricted stock activity for the three months ended March 31, 2022:

 

Restricted shares issued as of December 31, 2021

    141,250  

Granted

    37,500  

Vested and issued

    (66,249

)

Forfeited

    (30,001

)

Vested restricted shares as of March 31, 2022

    -  

Unvested restricted shares as of March 31, 2022

    82,500  

 

Restricted shares outstanding at December 31, 2021:

    1,318,679  

Forfeited

    (80,000

)

Total restricted shares outstanding at March 31, 2022:

    1,238,679  
         

Comprised of:

       

Vested restricted shares as of March 31, 2022

    678,679  

Unvested restricted shares as of March 31, 2022

    560,000  

Total

    1,238,679  

 

Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block]

The following table presents information related to warrants (ViralClear) at March 31, 2022:

 

 

Exercise

 

 

Number

 

Expiration

 

Price

 

 

Outstanding

 

Date

 

$

5.00

 

 

 

473,772

 

November 2027

 

 

10.00

 

 

 

6,575

 

May 2025

 

 

 

 

 

 

480,347